Patents by Inventor Mark Paul Diamond

Mark Paul Diamond has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating multiple sclerosis using antisense oligonucleotides
    Patent number: 8759314
    Abstract: A method for treating a patient suffering from multiple sclerosis, particularly a relapsing form of multiple sclerosis, comprising periodically administering a pharmaceutical composition comprising a therapeutically effective amount of OLIGONUCLEOTIDE 1 to the patient, thereby treating the patient.
    Type: Grant
    Filed: March 22, 2013
    Date of Patent: June 24, 2014
    Assignees: Antisense Therapeutics Limited, Teva Pharmaceutical Industries, Ltd.
    Inventors: Ety Klinger, Shoshi Tessler, Hallak Hussein, George Tachas, Mark Paul Diamond
  • METHODS FOR TREATING MULTIPLE SCLEROSIS USING ANTISENSE OLIGONUCLEOTIDES
    Publication number: 20130345293
    Abstract: A method for treating a patient suffering from multiple sclerosis, particularly a relapsing form of multiple sclerosis, comprising periodically administering a pharmaceutical composition comprising a therapeutically effective amount of OLIGONUCLEOTIDE 1 to the patient, thereby treating the patient.
    Type: Application
    Filed: March 22, 2013
    Publication date: December 26, 2013
    Applicants: TEVA PHARMACEUTICAL INDUSTRIES, LTD., ANTISENSE THERAPEUTICS LIMITED
    Inventors: Ety Klinger, Shoshi Tessler, Hussein Hallak, George Tachas, Mark Paul Diamond
  • Methods for treating multiple sclerosis using antisense oligonucleotides
    Patent number: 8415314
    Abstract: A method for treating a patient suffering from multiple sclerosis, particularly a relapsing form of multiple sclerosis, comprising periodically administering a pharmaceutical composition comprising a therapeutically effective amount of OLIGONUCLEOTIDE 1 to the patient, thereby treating the patient.
    Type: Grant
    Filed: June 23, 2009
    Date of Patent: April 9, 2013
    Assignees: Antisense Therapeutics Limited, Teva Pharmaceutical Industries, Ltd.
    Inventors: Ety Klinger, Shoshi Tessler, Hussein Hallak, George Tachas, Mark Paul Diamond
  • Methods for treating multiple sclerosis using antisense oligonucleotides
    Publication number: 20100119480
    Abstract: A method for treating a patient suffering from multiple sclerosis, particularly a relapsing form of multiple sclerosis, comprising periodically administering a pharmaceutical composition comprising a therapeutically effective amount of OLIGONUCLEOTIDE 1 to the patient, thereby treating the patient.
    Type: Application
    Filed: June 23, 2009
    Publication date: May 13, 2010
    Inventors: Ety Klinger, Shoshi Tessler, Hussein Hallak, George Tachas, Mark Paul Diamond